Navigation Links
Researchers discover new details about HIV-1 entry and infection

The primary targets of HIV-1 infection in the human vagina have been definitively identified in a new study published in the February 2007 issue of the journal Immunity, published by Cell Press. The findings are likely to guide development of new strategies that will prevent HIV-1 transmission.

"The majority of HIV-1 infected individuals worldwide are women who acquire HIV infection following sexual contact," explain study authors Dr. Florian Hladik and Dr. M. Juliana McElrath from the Fred Hutchinson Cancer Research Center. "Blocking HIV transmission and local spread in the female lower genital tract is key to prevent infection and ultimately to ease the pandemic."

Dr. Florian Hladik and colleagues in the McElrath laboratory developed a unique model system to study the precise mechanisms by which HIV-1 enters the lower reproductive tract of human females. The researchers separated and removed the outer lining of vaginal cells, which serves as the first barrier to the virus. The isolated preparation of intact, viable, vaginal epithelium permitted examination of immune cells that normally migrate out of the vaginal epithelium into deeper tissues shortly after exposure to HIV-1.

The researchers found that HIV-1 simultaneously enters two different types of intraepithelial cells associated with the immune system, Langerhans cells (LC) and CD4+ T cells. However, the path of entry and fate of infection was different for the two cell types. Infection of CD4+ T cells appears to rely at least in part on expression of major HIV-1 coreceptors like CCR5, whereas pathways for infection of vaginal LC appear to be more diverse and complex. In contrast to previous studies, infection of CD4+ T cells does not appear to require passage of the virus from LC.

Both LC and CD4+ T cells can migrate out of the vaginal epithelium. Study findings suggest that CD4+ T cells may be principally responsible for local shedding of the virus in the vagina of wom en infected with HIV-1 while LC may harbor viable virus for some time before spreading it to other cells.

These results reveal that it is necessary to consider mechanisms of viral entry into both CD4+ T and LC when searching for an effective way to interfere with infection through the vaginal epithelium. "Our findings provide exciting definitive insights into the initial events of HIV-1 infection in the human vagina, which can guide the design of effective strategies to block local transmission and prevent HIV-1 spread," concludes Dr. McElrath.
'"/>

Source:Cell Press


Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Researchers find how protein allows insects to detect and respond to pheromones
3. Researchers Uncover Key Step In Manufacture of Memory Protein
4. Researchers reveal the infectious impact of salmon farms on wild salmon
5. Researchers identify target for cancer drugs
6. Researchers discover molecule that causes secondary stroke
7. Researchers find missing genes of ancient organism
8. Researchers trace evolution to relatively simple genetic changes
9. Researchers add new tool to tumor-treatment arsenal
10. UF Researchers Map Bacterial Proteins That Cause Tooth Loss
11. VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/25/2019)... ... August 23, 2019 , ... Sierra Instruments is pleased ... to their online store are now live. Sierra has redesigned entry to the site ... format is more user-friendly and easier to navigate with streamlined menus and simple access ...
(Date:8/21/2019)... ... 2019 , ... AbSci, a revolutionary synthetic biology company with ... complex protein therapeutics, today announced the appointment of Fred Larimore, PhD, to Vice ... brings more than 30 years of experience in biopharmaceutical manufacturing and process development ...
(Date:8/19/2019)... , ... August 19, 2019 , ... ... tissues through the use of ultra-thin two dimensional slices which are placed on ... highly limited for complex tissues and complicated features such as vasculature and thus ...
Breaking Biology News(10 mins):
(Date:9/17/2019)... ... September 17, 2019 , ... Geneticure, Inc., a Rochester Minnesota ... that the U.S. Patent and Trademark Office (USPTO) and European Patent Office (EPO) ... recommendations for hypertension treatment. , The patent applies to Geneticure’s first pharmacogenomics ...
(Date:9/11/2019)... (PRWEB) , ... September 09, 2019 , ... ... life sciences companies and government agencies, announced that its president and CEO Maryann ... of successful business leaders. , The Forbes Council accepted Gallivan based on the ...
(Date:9/8/2019)... ... September 04, 2019 , ... The Blavatnik ... today the three Winners and six Finalists of the 2019 Blavatnik Regional ... across New York, New Jersey, and Connecticut since 2007, the Blavatnik Regional Awards ...
(Date:8/29/2019)... ... August 28, 2019 , ... DuPont Nutrition ... solutions to attendees at the International Baking Industry Expo, September 8 to 11, ... optimizing production efficiency to cost and waste reduction and from maintaining freshness throughout ...
Breaking Biology Technology: